Biodesix, Inc. (BDSX) vs InflaRx N.V. (IFRX)
A side-by-side comparison of Biodesix, Inc. and InflaRx N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDSX
Biodesix, Inc.
$28.32HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
IFRX
InflaRx N.V.
$1.60HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — BDSX vs IFRX
growth of $100 · dividends reinvested · last 6yBDSX -88.7% (-30.4%/yr)IFRX -60.3% (-14.3%/yr)IFRX compounded faster over this window
BDSX IFRX
BDSX vs IFRX: by the numbers
- •IFRX is the larger company ($236M vs $231M market cap).
- •Both run net losses; BDSX's is the smaller (-26.97% vs -155582.08% net margin).
Metrics side by side
Valuation
| Metric | BDSX | IFRX |
|---|---|---|
| P/S ratio | 2.24 | N/A |
| P/B ratio | 25.21 | 1.41 |
Profitability
| Metric | BDSX | IFRX |
|---|---|---|
| Gross margin | 82.50% | -24677.94% |
| Operating margin | -31.37% | -164525.50% |
| Net margin | -26.97% | -155582.08% |
| ROE | -303.61% | -27.27% |
| ROIC | -25.73% | -25.38% |
Growth (annualized)
| Metric | BDSX | IFRX |
|---|---|---|
| Revenue CAGR (5Y) | 5.99% | N/A |
| Total return CAGR (5Y) | -28.49% | -7.34% |
Frequently asked
- How have BDSX and IFRX total returns compared?
- Over the past 5 years, BDSX delivered -28.49% and IFRX delivered -7.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.